# Irigenin

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/irigenin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-30
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** O-methylated isoflavone, Iris isoflavone, Belamcanda isoflavone, Western Himalayan isoflavone, Blackberry lily isoflavone, Irigenin flavonoid

## Overview

Irigenin is a naturally occurring isoflavone found primarily in Iris species plants, including Belamcanda chinensis. It exerts its primary effects by modulating epithelial-mesenchymal transition (EMT) pathways and enhancing antioxidant enzyme activity, making it a subject of interest in oncology and [oxidative stress](/ingredients/condition/antioxidant) research.

## Health Benefits

• Demonstrates anti-metastatic effects in lung carcinoma cell lines by modulating EMT (in vitro evidence).[1][2]
• Reduces blue light-induced retinal damage in hARPE-19 cells by enhancing antioxidant defenses (preclinical study).[3]
• Inhibits cell migration and invasion in lung cancer by disrupting integrin interactions (preclinical evidence).[1][2]
• Activates Nrf2/HO-1 pathway to reduce [inflammation](/ingredients/condition/inflammation) and apoptosis in osteoarthritis rat models (animal study).[7]
• Enhances cellular [antioxidant activity](/ingredients/condition/antioxidant), reducing ROS and promoting [mitochondrial](/ingredients/condition/energy) health (in vitro evidence).[3]

## Mechanism of Action

Irigenin disrupts epithelial-mesenchymal transition (EMT) by downregulating key transcription factors such as Snail, Slug, and Vimentin while preserving E-cadherin expression, thereby inhibiting cell migration and invasion in lung carcinoma models. It also activates the Nrf2/HO-1 antioxidant signaling pathway, upregulating superoxide dismutase (SOD) and catalase to mitigate [reactive oxygen species](/ingredients/condition/antioxidant) (ROS)-induced cellular damage. Additionally, irigenin has been shown to modulate MMP-2 and MMP-9 matrix metalloproteinase activity, which are critical mediators of extracellular matrix degradation and tumor invasiveness.

## Clinical Summary

Current evidence for irigenin is limited exclusively to in vitro and preclinical cell-based studies, with no published human clinical trials as of 2024. In lung carcinoma cell line experiments (A549 and H1299 cells), irigenin treatment significantly reduced cell migration and invasion at concentrations ranging from 10–80 μM in dose-dependent fashion. A separate preclinical study using hARPE-19 retinal pigment epithelial cells demonstrated that irigenin reduced blue light-induced oxidative damage by enhancing [antioxidant](/ingredients/condition/antioxidant) enzyme expression. The overall evidence base is early-stage and requires validation in animal models and eventually randomized controlled trials before any clinical conclusions can be drawn.

## Nutritional Profile

Irigenin is a naturally occurring isoflavone (specifically an iris isoflavone) isolated primarily from the rhizomes of Iris species (e.g., Iris tectorum, Iris germanica) and some Belamcanda chinensis sources. It is not a macronutrient or micronutrient source itself but functions as a polyphenolic bioactive compound. Molecular weight: 300.26 g/mol (C16H12O6). It contains a characteristic isoflavone backbone with hydroxyl and methoxy substitutions at positions 5, 7, and 3' that contribute to its [antioxidant](/ingredients/condition/antioxidant) and bioactive properties. No meaningful caloric, protein, fiber, or mineral content is attributable to irigenin in isolation. Bioavailability data is limited; like most isoflavones, intestinal absorption is expected to be moderate and subject to first-pass hepatic [metabolism](/ingredients/condition/weight-management), with glucuronide and sulfate conjugates as likely circulating metabolites. Oral bioavailability is presumed low without formulation enhancement, consistent with the broader isoflavone class (~10–40% in comparable compounds). No established therapeutic dosing range has been validated in human clinical trials.

## Dosage & Preparation

No clinically studied dosage ranges are available for irigenin. Preclinical in vitro studies used 10–50 μM for cancer cell inhibition, and related compounds like iridin were dosed at 20–80 mg/kg in mice. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

No human safety data or clinical toxicology profiles currently exist for irigenin as an isolated compound, as all studies have been conducted in vitro. Because irigenin is an isoflavone, it may theoretically exhibit weak estrogenic or anti-estrogenic activity by interacting with estrogen receptors (ERα/ERβ), warranting caution in hormone-sensitive conditions such as estrogen receptor-positive breast cancer or endometriosis. Potential interactions with cytochrome P450 enzymes (particularly CYP1A2 and CYP3A4) have not been characterized, so concurrent use with pharmaceuticals metabolized by these enzymes should be approached with caution. Pregnant and breastfeeding women should avoid irigenin supplementation entirely due to the complete absence of safety data in these populations.

## Scientific Research

No human clinical trials or meta-analyses are available for irigenin. Preclinical studies include anti-metastatic effects in lung carcinoma cell lines (PMID: 27849000) and retinal damage reduction in cell models.

## Historical & Cultural Context

Irigenin is derived from ethno-medicinal plants of the Western Himalayan region and Belamcanda chinensis. It has been used in traditional systems, though specific historical uses and durations are not detailed in the available research.

## Synergistic Combinations

Irigenin pairs well with Quercetin, as both activate the Nrf2/HO-1 [antioxidant](/ingredients/condition/antioxidant) pathway through overlapping but complementary mechanisms — quercetin's Keap1 disruption may amplify irigenin's HO-1 upregulation additively. Piperine (from black pepper, ~5–20 mg range) is a logical co-ingredient because it inhibits CYP3A4 and UGT enzymes that rapidly metabolize isoflavones, potentially improving irigenin's oral bioavailability significantly (a well-documented mechanism with structurally similar isoflavones like genistein). Additionally, Resveratrol complements irigenin's anti-metastatic profile by independently targeting MMP-2/MMP-9 matrix metalloproteinase activity and interleukin signaling in carcinoma models, providing additive suppression of EMT pathways that irigenin modulates via integrin disruption.

## Frequently Asked Questions

### What plant is irigenin found in naturally?

Irigenin is primarily isolated from Iris species plants, most notably Belamcanda chinensis (blackberry lily), which has a history of use in traditional Chinese medicine. It is also found in other members of the Iridaceae family, where it occurs alongside related isoflavones such as tectorigenin and iridin. These plants have been used historically for anti-inflammatory and antimicrobial purposes, which aligns with irigenin's emerging bioactivity profile.

### Can irigenin help fight lung cancer?

Irigenin has demonstrated anti-cancer activity specifically in lung carcinoma cell lines (A549 and H1299) in vitro, where it inhibited cell migration, invasion, and epithelial-mesenchymal transition at concentrations of 10–80 μM. These effects were linked to suppression of Snail, Slug, and Vimentin proteins and downregulation of MMP-2 and MMP-9. However, no animal studies or human trials have been conducted, so it cannot be recommended as a cancer treatment at this time.

### What is epithelial-mesenchymal transition (EMT) and how does irigenin affect it?

Epithelial-mesenchymal transition (EMT) is a biological process by which cancer cells lose their cell-to-cell adhesion properties and gain the ability to migrate and invade other tissues, a critical step in metastasis. Irigenin inhibits EMT by preserving the expression of E-cadherin, an adhesion protein that keeps cells anchored, while simultaneously suppressing mesenchymal markers like Vimentin and transcription factors Snail and Slug. This dual action effectively reduces the metastatic potential of lung carcinoma cells in laboratory settings.

### Does irigenin protect the eyes from blue light damage?

Preclinical research using hARPE-19 human retinal pigment epithelial cells found that irigenin reduced blue light-induced oxidative damage by activating the Nrf2/HO-1 signaling pathway and upregulating antioxidant enzymes including superoxide dismutase (SOD) and catalase. This suggests a potential protective role for retinal health under conditions of oxidative stress caused by high-energy visible light. These findings are preliminary and have not been replicated in animal models or human subjects.

### Is irigenin safe to take as a supplement?

There is currently no established safety profile, recommended dosage, or human toxicology data for irigenin as a dietary supplement, since all research has been conducted in cell cultures. As an isoflavone, it may interact with estrogen receptors, which could be problematic for individuals with hormone-sensitive conditions or those taking hormonal medications. Until clinical studies are completed, irigenin supplementation cannot be considered safe or evidence-based for human use.

### What does the research evidence show about irigenin's effectiveness in humans versus laboratory studies?

Current evidence for irigenin comes primarily from in vitro (cell culture) and animal studies demonstrating anti-metastatic and antioxidant effects, but human clinical trials are lacking. Most published research involves lung cancer cell lines and cultured retinal cells, which means effectiveness in living humans remains unproven. The gap between preclinical findings and clinical efficacy is significant, and more rigorous human studies would be needed to establish real-world benefits. Consumers should be aware that promising laboratory results do not automatically translate to safe or effective human supplementation.

### Does irigenin interact with common cancer medications or chemotherapy drugs?

Specific drug interaction data for irigenin with chemotherapy or cancer medications is not well-documented in published literature. Because irigenin modulates cell signaling pathways (particularly EMT and Nrf2/HO-1), there is theoretical potential for interactions with drugs that rely on similar mechanisms, though this has not been clinically tested. Anyone taking prescription cancer treatments or other medications should consult a healthcare provider before using irigenin supplements, as pathway interactions could affect drug efficacy or safety. Current evidence is insufficient to rule out clinically relevant interactions.

### What natural food sources contain meaningful amounts of irigenin, and can diet alone provide therapeutic levels?

Irigenin is naturally present in iris plants and certain botanical sources, but dietary concentrations in common foods are not well quantified in scientific literature. The bioavailability and absorption of naturally occurring irigenin from food sources remain unstudied, making it unclear whether dietary intake could achieve the concentrations used in laboratory studies. Most research demonstrating irigenin's effects uses isolated compound or extract forms rather than whole-food sources. It is currently unknown whether food-based consumption can deliver sufficient amounts for any claimed health benefit.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*